Maestu et al., 2005 - Google Patents
Evidence of biochemical and biomagnetic interactions in Alzheimer's disease: an MEG and MR spectroscopy studyMaestu et al., 2005
- Document ID
- 1475945879857624555
- Author
- Maestu F
- Garcia-Segura J
- Ortiz T
- Montoya J
- Fernandez A
- Gil-Gregorio P
- Campo P
- Fernandez S
- Viano J
- Portera A
- Publication year
- Publication venue
- Dementia and geriatric cognitive disorders
External Links
Snippet
Background: Several neuroimaging studies have shown reliable differences between Alzheimer's disease (AD) patients and age-matched controls. However, few studies have demonstrated the interactions between neuroimaging methods for the diagnoses of AD …
- 206010001897 Alzheimer's disease 0 title abstract description 85
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/563—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution of moving material, e.g. flow contrast angiography
- G01R33/56341—Diffusion imaging
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/4806—Functional imaging of brain activation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/483—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves involving electronic or nuclear magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
- A61B5/4064—Evaluating the brain
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/0033—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room
- A61B5/004—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for image acquisition of a particular organ or body part
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Metwalli et al. | Utility of axial and radial diffusivity from diffusion tensor MRI as markers of neurodegeneration in amyotrophic lateral sclerosis | |
Landin-Romero et al. | Disease-specific patterns of cortical and subcortical degeneration in a longitudinal study of Alzheimer's disease and behavioural-variant frontotemporal dementia | |
Fernández et al. | Focal temporoparietal slow activity in Alzheimer’s disease revealed by magnetoencephalography | |
Gao et al. | Changes of brain structure in Parkinson’s disease patients with mild cognitive impairment analyzed via VBM technology | |
Martin et al. | Translating state-of-the-art spinal cord MRI techniques to clinical use: A systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI | |
Foerster et al. | 25 years of neuroimaging in amyotrophic lateral sclerosis | |
Ding et al. | Physiological neuronal decline in healthy aging human brain—an in vivo study with MRI and short echo-time whole-brain 1H MR spectroscopic imaging | |
Kubicki et al. | Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study | |
Kantarci et al. | Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease | |
Cazettes et al. | Obesity-mediated inflammation may damage the brain circuit that regulates food intake | |
Kristo et al. | Task and task‐free FMRI reproducibility comparison for motor network identification | |
Bonekamp et al. | Diffusion tensor imaging in children and adolescents: reproducibility, hemispheric, and age-related differences | |
Koch et al. | Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer's disease | |
Yu et al. | Multiple white matter tract abnormalities underlie cognitive impairment in RRMS | |
Cecchetti et al. | Resting-state electroencephalographic biomarkers of Alzheimer’s disease | |
Wilde et al. | Brain imaging correlates of verbal working memory in children following traumatic brain injury | |
Travis et al. | Abnormal white matter properties in adolescent girls with anorexia nervosa | |
Wiesman et al. | The impact of age and sex on the oscillatory dynamics of visuospatial processing | |
Mascali et al. | Disruption of semantic network in mild Alzheimer’s disease revealed by resting-state fMRI | |
Gianaros et al. | Is there a functional neural correlate of individual differences in cardiovascular reactivity? | |
Thomann et al. | Structural changes of the corpus callosum in mild cognitive impairment and Alzheimer’s disease | |
Tan et al. | Structural connectome alterations in patients with disorders of consciousness revealed by 7-tesla magnetic resonance imaging | |
Bonzano et al. | Structural connectivity influences brain activation during PVSAT in multiple sclerosis | |
Mory et al. | Structural abnormalities of the thalamus in juvenile myoclonic epilepsy | |
US20050085705A1 (en) | fMRI system for use in detecting neural abnormalities associated with CNS disorders and assessing the staging of such disorders |